← brief for 2026-09-22 · Slowing decline

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Trial No results yet Not peer reviewed

Key takeaways

This is a new study that is just starting. It will test a drug called clazakizumab in adults with high inflammation markers. The goal is to see if it lowers the risk of heart problems. There are no results yet.

Who did this work

Run by Eli Lilly and Company. Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST) (Eli Lilly and Company)
Sites: Heart Center Research, LLC · Pima Heart · Eclipse Clinical Research · Thrive Clinical Research Group · Omega Research Orlando · American Research Institute

Source

Trial · ClinicalTrials.gov, CKD recruiting · 2026-09-22
https://clinicaltrials.gov/study/NCT07783802